UPDATE: Morgan Stanley Raises Price Target on CVS to $47

by Benzinga Staff
January 3, 2012 6:57 AM | 23 seconds read | Make a Comment

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

According to Morgan Stanley, CVS/Caremark (NYSE: CVS) price target is increased to $47.Morgan Stanley said that margin expansion and what we expect to be another strong selling season should support current multiples. “Our new $47 price target assumes current 14.5 multiple applied to our CY12 forecast of $3.25. Our CY13 estimate of $3.77 is ~4% higher then consensus reflecting our assumptions regarding an accelerating benefit from generics in next 18-months.”CVS/Caremark closed on Friday at $40.78.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetAnalyst RatingsMorgan Stanley

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.